Insiders Bal Pharma Limited

Equities

BALPHARMA

INE083D01012

Market Closed - Bombay S.E. Other stock markets 11:00:49 11/06/2024 BST			5-day change	1st Jan Change
120.8 ^INR	+1.17%		+15.16%	+20.15%

05-28	Bal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-12	Bal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bal Pharma Limited Appoints Abdul Basith as Company Secretary and Compliance Officer	17/07/23	CI
Bal Pharma Limited Appoints Nicola Neeladri as Additional Director	01/06/23	CI
Bal Pharma Limited Announces Resignation of Mrs.Preeti Singh as Company Secretary	15/05/23	CI
Bal Pharma CFO Resigns	25/11/22	MT
Bal Pharma Limited Announces Resignation of Mr. G. Rengarajan as Chief Financial Officer	24/11/22	CI
Bal Pharma Limited Appoints Kotian Chittananda Damodar as Additional Director (Non Independent)	30/05/22	CI
Bal Pharma Ltd Announces the Launch of Favipiravir Formulation into Indian Market, Under the Brand Name BALflu	24/05/21	CI
Bal Pharma Limited Announces Demise of Dr. Subba Rao Prasanna, Former Director and Promoter	21/05/21	CI
Bal Pharma Limited Appoints Jatish Sheth as Additional Director	28/12/20	CI
Bal Pharma Limited Announces Executive Changes	23/05/20	CI
Bal Pharma Limited Announces Resignation of S. Pramod Kumar from the Directorship of the Company	25/02/20	CI
Bal Pharma Limited Announces Executive Appointments	28/09/19	CI
Bal Pharma Limited Appoints C. V. Srinivas as Independent and Non-executive Director	29/06/19	CI
Bal Pharma Limited Accepts Resignation of Anika Merciline from the Position of Company Secretary and Compliance Officer	29/06/19	CI
Bal Pharma Limited Announces Resignation of G.S.R Subba Rao as Independent and Non Executive Director, Effective on March 31, 2019	26/03/19	CI
Bal Pharma Limited Appoints S.Anika Mercylin as Company Secretary and Compliance Officer	27/12/18	CI
Bal Pharma Limited Appoints A.N.V.K Chaitanya as Chief Financial Office and Key Managerial Personnel	10/08/18	CI
Bal Pharma Limited Announces Resignation of Sanjay Kumar Agarwal as Chief Financial Officer and Company Secretary	14/02/18	CI
Bal Pharma Limited Informs the Resignation of Shrenik Dheerajmal Siroya as Non- Executive Director	31/10/17	CI
Bal Pharma Limited Appoints Akash Mathur as Chief Executive Officer, Effective September 01, 2016	29/08/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bal Pharma Limited

Equities

BALPHARMA

INE083D01012

Insiders

Filters